ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $2.71 billion. The enterprise value is $2.19 billion.
| Market Cap | 2.71B |
| Enterprise Value | 2.19B |
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 166.39 million shares outstanding. The number of shares has increased by 1.65% in one year.
| Current Share Class | 166.39M |
| Shares Outstanding | 166.39M |
| Shares Change (YoY) | +1.65% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 60.97% |
| Float | 108.96M |
Valuation Ratios
The trailing PE ratio is 20.96 and the forward PE ratio is 29.81.
| PE Ratio | 20.96 |
| Forward PE | 29.81 |
| PS Ratio | 2.89 |
| Forward PS | 2.62 |
| PB Ratio | 4.69 |
| P/TBV Ratio | 5.74 |
| P/FCF Ratio | 13.36 |
| P/OCF Ratio | 13.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.59, with an EV/FCF ratio of 10.81.
| EV / Earnings | 17.05 |
| EV / Sales | 2.36 |
| EV / EBITDA | 17.59 |
| EV / EBIT | 19.52 |
| EV / FCF | 10.81 |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.29 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | 0.24 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 27.36% and return on invested capital (ROIC) is 13.41%.
| Return on Equity (ROE) | 27.36% |
| Return on Assets (ROA) | 8.72% |
| Return on Capital (ROIC) | 13.41% |
| Revenue Per Employee | $1.55M |
| Profits Per Employee | $214,893 |
| Employee Count | 598 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 8.49 |
Taxes
In the past 12 months, ACAD has paid $8.19 million in taxes.
| Income Tax | 8.19M |
| Effective Tax Rate | 5.99% |
Stock Price Statistics
The stock price has decreased by -28.77% in the last 52 weeks. The beta is 0.38, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -28.77% |
| 50-Day Moving Average | 15.61 |
| 200-Day Moving Average | 17.34 |
| Relative Strength Index (RSI) | 51.85 |
| Average Volume (20 Days) | 1,444,480 |
Short Selling Information
The latest short interest is 9.53 million, so 5.73% of the outstanding shares have been sold short.
| Short Interest | 9.53M |
| Short Previous Month | 8.18M |
| Short % of Shares Out | 5.73% |
| Short % of Float | 8.75% |
| Short Ratio (days to cover) | 8.43 |
Income Statement
In the last 12 months, ACAD had revenue of $929.24 million and earned $128.51 million in profits. Earnings per share was $0.78.
| Revenue | 929.24M |
| Gross Profit | 582.05M |
| Operating Income | 112.24M |
| Pretax Income | 45.74M |
| Net Income | 128.51M |
| EBITDA | 124.54M |
| EBIT | 112.24M |
| Earnings Per Share (EPS) | $0.78 |
Balance Sheet
The company has $565.33 million in cash and $49.37 million in debt, giving a net cash position of $515.96 million or $3.10 per share.
| Cash & Cash Equivalents | 565.33M |
| Total Debt | 49.37M |
| Net Cash | 515.96M |
| Net Cash Per Share | $3.10 |
| Equity (Book Value) | 577.18M |
| Book Value Per Share | 3.47 |
| Working Capital | 444.34M |
Cash Flow
In the last 12 months, operating cash flow was $202.73 million and capital expenditures -$70,000, giving a free cash flow of $202.66 million.
| Operating Cash Flow | 202.73M |
| Capital Expenditures | -70,000 |
| Free Cash Flow | 202.66M |
| FCF Per Share | $1.22 |
Margins
Gross margin is 62.64%, with operating and profit margins of 12.08% and 13.83%.
| Gross Margin | 62.64% |
| Operating Margin | 12.08% |
| Pretax Margin | 14.71% |
| Profit Margin | 13.83% |
| EBITDA Margin | 13.40% |
| EBIT Margin | 12.08% |
| FCF Margin | 9.04% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.65% |
| Shareholder Yield | -1.65% |
| Earnings Yield | 4.75% |
| FCF Yield | 7.49% |
Analyst Forecast
The average price target for ACAD is $26.44, which is 62.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.44 |
| Price Target Difference | 62.51% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 15.97% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 3.53 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.53 |
| Piotroski F-Score | 6 |